Live Breaking News & Updates on Moonlake Lee|Page 5

Stay updated with breaking news from Moonlake lee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

'Aggressive therapy' key in axial spondyloarthritis despite lack of T2T recommendation

SAN DIEGO — Although current American College of Rheumatology guidelines eschew treat-to-target for axial spondyloarthritis, “aggressive treatment” is still needed to manage the disease, noted a speaker here. ....

United States , Byerich Martin , Deodhara Spondyloarthritis , Eli Lilly , Bristol Myers Squibb , Science University , American College Of Rheumatology , Oregon Health , Patricia Nale , Clinical Rheumatology West , American College , Clinical Rheumatology ,

AS Patients Without Spinal Fusion Are a Distinct Subgroup

A small minority of patients with long-standing ankylosing spondylitis and fused sacroiliac joints lack syndesmophytes and were more likely to be HLA-B27 positive and female, a study found. ....

United States , University Of Texas , Laurenk Ridley , Eli Lilly , Marina Magrey , Bristol Myers Squibb , Centers For Translational Science Award , University Of Texas Health Center , Skin Diseases Intramural Research Program , National Institute Of Arthritis , Translational Sciences , Spondyloarthritis Association Of America , Texas Health Science Center , Prospective Study , Ankylosing Spondylitis , Stoke Ankylosing Spondylitis Scoring System , Rheumatic Diseases , Case Western Reserve University , Translational Science Award , National Institute , Spondyloarthritis Association , Texas Health Center , Ankylosing Spondylitis Bechterews Disease , Oint Inflammation , Spinal Fusion , Pain Management ,

MoonLake Immunotherapeutics AG: MoonLake Immunotherapeutics to initiate global Phase 2 study of the Nanobody sonelokimab in patients with active psoriatic arthritis

MoonLake Immunotherapeutics to initiate global Phase 2 study of the Nanobody sonelokimab in patients with active psoriatic arthritis MoonLake announces FDA clearance for Phase ....

United States , Mary Jane Elliott , Kristian Reich , Moonlake Immunotherapeutics , Patricia Sousa , Matthias Bodenstedt , Matthew Cole , Drug Administration , Health Assessment Questionnaire , American College Of Rheumatology , Consilium Strategic Communications , American College , Psoriasis Area , Severity Index , Chief Scientific Officer , Health Assessment Questionnaire Disability Index , Leeds Enthesitis Index , Patients Assessment , Arthritis Pain , Global Assessment Score , Securities Litigation Reform Act ,

MoonLake Immunotherapeutics AG: MoonLake Immunotherapeutics signs development and manufacturing agreement with Vetter Pharma International GmbH

MoonLake Immunotherapeutics signs development and manufacturing agreement with Vetter Pharma International GmbH ZUG, Switzerland, July 26, 2022 - MoonLake Immunotherapeutics AG (MoonLake; Nasdaq: MLTX) ....

Mary Jane Elliott , Oliver Daltrop , Moonlake Immunotherapeutics , Matthias Bodenstedt , Matthew Cole , Exchange Commission , Vetter Pharma International Gmbh , Vetter Pharma International Gmb , Master Development Services Agreement , Consilium Strategic Communications , Vetter Pharma International , Good Manufacturing Practice , Chief Technical Officer , Senior Vice Presidentkey Account Management , Supply Chain Management , Global Assessment Score , Psoriasis Area , Severity Index , Securities Litigation Reform Act , Current Report ,

European AxSpA Guidelines Reflect Recent Changes in Drug Therapy

Recommendations for the management of patients with axial spondyloarthritis (axSpA) emphasize both pharmacologic and nonpharmacologic therapies. ....

United States , San Francisco , Lianne Gensler , Eli Lilly , University Of California , American College Of Rheumatology , Assessment Of Spondyloarthritis International Society , European Alliance Of Associations , Leiden University Medical Center , Sofia Ramiro , European Alliance , Spondyloarthritis International Society , Closer Look , New Recommendations , Medscape Medical , Merck Sharp , Presented June , Ankylosing Spondylitis , Ankylosing Spondylitis Bechterews Disease , Clinical Guidelines , Oint Inflammation , Biologic Therapy , Inflammatory Bowel Disease , Nflammatory Bowel Disease Ibd , Intraocular Inflammation , Disease Modifying Antirheumatic Drugs Dmards ,